Atlas Trials

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

Clinical trial NCT05053503 · COMPLETED

Trial details

NCT number
NCT05053503
Sponsor
Spark Biomedical, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Opioid-use DisorderOpioid Withdrawal
Start date
2022-05-27
Primary completion
2025-04-04
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.